Hepatocellular carcinoma (HCC) is the sixth leading cause of cancer-related mortality worldwide.1 Despite therapeutic ...
Researchers led by a team from Mass General Brigham and the Ragon Institute have discovered why some people living with HIV who are given a treatment called broadly neutralizing anti-HIV antibodies ...
The Editorial Office of Protein & Cell is pleased to announce the publication of a new research article by Wang et al., ...
Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...
In a new study, researchers from the University of Chicago discovered that zeaxanthin, a plant-derived carotenoid best known for protecting vision, may also act as an immune-boosting compound by ...
People infected with HIV must take antiretroviral drugs for life. But engineered antibodies appeared to suppress the virus ...